1
2
3

Information List

Wuxi Beta Obtain High-tech Enterprise Certificate

2018-10-25

On December 7, 2017, Wuxi Beta Pharmaceutical Technology Co., Ltd. obtained the certificate of high-tech enterprise in Jiangsu Province. So far, Wuxi Beta has obtained a total of 16 patents, published 9 academic papers in well-known journals and academic conferences at home and abroad, overcome a number of technical difficulties, created 5 "gold standard" products and technologies, and developed more than 400 kinds of isotope labeling products. These technological innovations have brought broad development prospects to Wuxi Beta.

Two Australians saved 0.8 billion lives in China! So won the Nobel Prize!

2018-10-25

2017-08-2216:41 Microbiology On December 10, 2005, the annual Nobel Prize Ceremony was held as scheduled in Stockholm, Sweden. When the dean of the Karolinska Institute announced the ownership of the medical award that year, the flash of the audience gathered on the two Australians. Rubin Warren (RobinWarren) and Barry Marshall (BarryMarshall), these two names will be solemnly recorded in history from that moment on-their understanding of "Helicobacterpylori-secluded."

Changsha is expected to produce carbon -13 labeled products and detection reagents.

2018-07-19

Xinhua News Agency, December 5 (Reporter Xiong Yuanfan) at the 2014 Human Resources work Conference of Changsha Economic Development Zone held today, seven entrepreneurial and innovative projects, such as "Development of carbon -13 isotope labeled precursor compounds and internal standard detection reagents", received financial support from 6.3 million yuan, and carbon -13 labeled products and detection reagents are expected to be manufactured in Changsha. Newborns are screened for genetic and metabolic diseases, and the key substance in the kit used for testing is carbon -13 or carbon -14. These two carbon isotopes are widely used for labeling bioactive molecules, labeling biological test reagents and small molecule pharmaceuticals. For example, gastric cancer patients carry stomach

Nobel Prize Winner Joins Hands with Jiangyin Enterprise to Set up Research Institute

2018-07-19

Reprint: Jiangsu Science and Technology News (correspondent Liu Jiajia, Li Neng and reporter Ma Yang) On the morning of November 23, Wuxi Beta Pharmaceutical Technology Co., Ltd. and the 2005 Nobel Prize winner in chemistry and California Institute of Technology professor Robert Grubb The China (Jiangyin) Research Institute for Isotope Labeling was officially unveiled, and the Chinese Academy of Engineering Academician Zhou Yongmao's workstation was also established. The Grubb Isotope Labeling China (Jiangyin) Research Institute is led by Professor Robert Grubb, relying on the world-leading laboratory technology platform of Beta Pharmaceutical Company to research and innovate 13C, 14C and other isotope labeling products.

Grubb Isotope Labeling China (Jiangyin) Research Institute Settles in High-tech Zone

2018-07-19

Reprint: On the morning of November 23, China Jiangyin Party and Government Network, Grubb Isotope Labeling China (Jiangyin) Research Institute and Academician Zhou Yongmao's Workstation held an inauguration ceremony. So far, our city has introduced 5 high-end talents who have won the Nobel Prize, of which 4 have set up research institutes in Jiangyin, and 36 academician workstations have settled in our city. Robert Grubb, Nobel Laureate in Chemistry and professor of the California Institute of Technology, Zhou Yongmao, academician of the Chinese Academy of Engineering, and city leaders Shen Jian, Qian Wenqin, Feng Aidong, Fei Ping, and Yu Xinquan attended the inauguration ceremony. Municipal Standing Committee, Organization Department Minister Qian Wenqin presided over the ceremony. Mayor Shen Jianzhi

Grubb Isotope Labeling China (Jiangyin) Research Institute Unveiled

2018-07-19

Reprint: The original title of People's Daily Online: Jiangyin once again joined hands with the Nobel Prize winner. On the morning of November 23, the Grubb isotope marker created by Wuxi Beta Pharmaceutical Technology Co., Ltd. and Nobel Prize winner in chemistry and California Institute of Technology Professor Robert Grubb The China (Jiangyin) Research Institute was officially unveiled, and Academician Zhou Yongmao's workstation was also established. This is the fourth Nobel laureate research institute and the 36th academician workstation established since Jiangyin vigorously implemented the "talent strengthening enterprise 330 plan", which fully demonstrates the achievements of the city's talent recruitment work. It is reported that the Grubb isotope labeling China (Jiangyin) Research Institute by Robert Guerra

Japan's Shimadzu to buy clinical isotope labeling company AlsaChim

2018-10-25

Instrument Information Network 2017/06/22 [Introduction] In the face of the global wave of clinical mass spectrometry, even Shimadzu, which rarely participates in capital operation, has recently revealed acquisition news: Shimadzu announced that it has wholly acquired AlsaChim, an independent contract research and development institution in France, through Shimadzu Europe. The global scientific instrument industry is changing, and the merger and acquisition integration between enterprises is continuous. However, compared with the "frequent moves" of European and American companies such as Syme Fly and Danaher, the mergers and acquisitions of Japanese companies appear to be "implicit" a lot. Nevertheless, in the face of global clinical mass spectrometry waves.

China's Food and Drug Administration Becomes a Full Member of the International Technical Coordination Committee for Registration of Medicines for Human Use (ICH)

2018-10-25

On June 19, 2017, the State Food and Drug Administration announced that it has become a full member of the International Technical Coordination for Registration of Medicines for Human Use (ICH). It means that China's drug regulatory authorities, pharmaceutical industry and R & D institutions will gradually transform and implement the highest international technical standards and guidelines, and actively participate in the formulation of rules, which will promote innovative drugs to meet the clinical drug needs of patients at home and abroad as soon as possible, and enhance the innovation ability and international competitiveness of the domestic pharmaceutical industry. ICH was established in 1990 by the United States, the European Community and Japan tripartite drug regulatory authorities and industry associations, and in.

Wuxi Beta establishes partnership with Swiss RC TRITECH

2018-10-25

On May 15, 2017, Wuxi Beta Pharmaceutical Technology Co., Ltd. established a cooperation with Swiss RCTRITECH Company to provide technical services for tritium labeling for new drug development in China. In our country, the tritium label of drugs has not been provided by professional companies. This cooperation will provide great convenience for our customers who need tritium label and open up a shortcut for the development of tritium label technology in our country.

Wuxi Beta Obtain C- 14 and H-3 Radiation Safety License

2018-10-25

On May 15, 2017, Wuxi Beta Pharmaceutical Technology Co., Ltd. completed the construction of a non-sealed radioactive material workplace and obtained a C- 14 and H-3 radiation safety license. Wuxi Beta has been engaged in the simulation research and development of C14 labeled precursor compounds since 2009 and the cooperative research and development of C14 source materials since 2010. By October 2016, these tasks have been basically completed and a solid foundation for development has been established. At this time, the acquisition of radiation safety license marks the formal opening of China's professional C14 marking service.

< 1234567 >